Theramyt is a unique bio-enterprise building tomorrow’s biologics – biobetters. We apply our drug designing and platform technology strengths to deliver novel therapies for disease areas such as oncology, rheumatoid arthritis, diabetes and metabolic disorders.

We optimise processes to generate niche biological products, with greater yield and quality, supported by intensive characterisation packages.

Powered by robust glyco-engineered therapeutics and protein display platforms, we deliver biobetters with greater efficacy and improved treatment outcomes.

Through strategic partnerships, we build a portfolio of block-buster drugs, which shape the future of biological interventions.